Navigation Links
Frost & Sullivan Commends Isobionics for Technology Innovation
Date:9/22/2010

LONDON, Sept. 22 /PRNewswire/ -- The 2010 Frost & Sullivan Global Technology Innovation Award in Food Ingredients is presented to Isobionics. The company offers guaranteed supply and consistent high quality of Valencene Pure™ - a natural flavour molecule for orange notes - based on a unique fermentation process.

(Logo:  http://photos.prnewswire.com/prnh/20081117/FSLOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

Valencene Pure™ is produced from a new biotechnological process developed and implemented by the company through in-house research efforts. Combining fermentation with biotransformation, this innovative method addresses the issue of cost-effectively and easily producing natural flavour profiles.

"Isobionics can rightly claim to be the first company to have targeted a molecule rationally for synthesis using biotransformation technology," notes Frost & Sullivan Research Analyst Dr. Kaushik Shankar. "Isobionics' unique process has enabled the introduction of Valencene Pure™ within three years from the date of patenting the idea, indicative of the robustness of the process and the confidence of the company in the technology."

Consistent supply and high cost have been the main factors impeding the shift from synthetic flavour compounds to natural and nature identical flavours across food applications. With a nearly 10 fold decrease in anticipated cost of using Valencene Pure™ compared to orange derived valencene, the issue of cost is addressed with ease.

Moreover, the controlled fermentation method employed for production uses commonly available feedstock, glucose. Hence Isobionics can comfortably satisfy the demands for valencene worldwide with their proprietary product derived from patented technology.

"By recreating the exact molecule that is obtained from Valencia oranges, Isobionics has added value to a product that is normally dependent on agricultural production cycles," adds Dr. Shankar. "Standardisation is achieved both on molecular consistency and pricing."

The important feature of the technology employed for production of Valencene Pure™ is the scalability. This allows for quick upgrades of production capacities, which is impossible in agriculture derived ingredients.

As a result of the technology employed for the synthesis of the molecule, Valencene Pure™ is available in a concentration much higher than orange derived valencene, Furthermore, the development of flavour profiles based on Valencene Pure™ is easier since it requires only minor tweaking.

"Food manufacturers can make use of Valencene Pure™ to create natural grapefruit notes in their products without having to worry about quality issues that plague natural extracts," remarks Dr. Shankar. "While concentrations of the active molecules are consistent, there are little or no associated impurities with the product like insecticide residues, which are common in natural products. This results in greater customer confidence."

The technology developed by Isobionics reduces the amount of energy embodied in the production process for valencene and therefore enables the creation of a more environment friendly product. Manufacturers may also be able to develop products with the ultimate aim of reducing the footprint of their final product, using ingredients such as Valencene Pure™.

The Technology Innovation Award is presented to the company that has excelled in the following criteria: uniqueness of technology, impact on new products/applications, impact on functionality, impact on customer value and relevance of innovation to industry.

Frost & Sullivan Best Practices Awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About IsobionicsIsobionics is a Dutch biotechnology company run by experienced technologists and professionals. The company has a portfolio of natural products, each one unique in its production method and functional features. The company has a vision of developing high quality products based on sound technologies. The development of technologies is the company's core strength, which also enables it to provide value-added services to its customers. Isobionics has an Intellectual property portfolio comprising varied biotechnological aspects including metabolic engineering, biochemical engineering, downstream processing and upscaling. The company prides itself on its "win-win" approach in working with the customer for developing new products and technologies.

About Frost & SullivanFrost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents. To join our Growth Partnership, please visit http://www.awards.frost.com.Contact:Catherine BrassellBest PracticesFrost & Sullivancatherine.brassell@frost.comP: +44.207.915.7867
'/>"/>

SOURCE Frost & Sullivan
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Frost & Sullivan Recognizes Algasol Renewables for its Micro Algae Biomass Production System
2. Excellence in Healthcare Innovation Recognized by Frost & Sullivan
3. Frost & Sullivan Reveals Strategies on Turning Challenges into Opportunities in the European Biomarkers Market
4. Frost & Sullivan Recognizes Agile Therapeutics for Its Innovative Weekly Low-Dose Contraceptive Patch
5. Frost & Sullivans 2009 Excellence in Healthcare Awards Banquet Honours Industrys Top Performers
6. Frost and Sullivan Honors Oramed Pharmaceuticals With the 2009 European Oral Drug Delivery Technology Innovation Award
7. Emergence of Newer Drug Classes to Treat Diabetes and Co-morbidities Key to Market Expansion, Reveals Frost & Sullivan
8. PROLOR Biotech Announces $10 Million Preferred Stock Line From Members of The Frost Group
9. Growing Awareness and Increased Investments Lead to Growth of Biotechnology Applications in the Food & Beverage and Dietary Supplements Sector, Reveals Frost & Sullivan
10. Big Pharma to Big Biopharma: Frost & Sullivan Examines the Latest M&A Trends and Opportunities
11. SyntheMed Receives Frost & Sullivan Health Innovation Award Nomination
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... SAN DIEGO , Feb. 23, 2017 /PRNewswire/ ... protein research tools, announced the acquisition of GenWay ... with a comprehensive service and product offering for ... "This acquisition will facilitate growth and enhance capabilities ... proteins, antibodies, and ELISA assays will nicely complement ...
(Date:2/22/2017)... LEAWOOD, Kan. , Feb. 22, 2017  Aratana Therapeutics, ... licensing, development and commercialization of innovative biopharmaceutical products for companion ... 14, 2017 at 8:30 a.m. ET to discuss financial results ... 2016. Interested participants and investors may access ... dial-in: ...
(Date:2/22/2017)... -- PrimeVax Immuno-Oncology, Inc. announced today its CEO, Tony ... Global Life Science Partnering Conference.  The presentation will take ... Torrey Pines Lodge, in San Diego.  ... have chosen our company, amongst numerous others, to present ... clinical researchers," said Mr. Chen. "In contrast to conferences ...
(Date:2/22/2017)... ... February 22, 2017 , ... ProMIS Neurosciences (“ProMIS” ... for neurodegenerative diseases, today announced it has issued a scientific white paper entitled ... of a series of commentaries from ProMIS’s scientific team offering insight into the ...
Breaking Biology Technology:
(Date:1/24/2017)... 24, 2017  It sounds simple and harmless—an ... monitors vital signs and alerts parents on their ... saturation level drops. But pediatric experts argue that ... with no evidence of medical benefits, especially to ... aggressively to parents of healthy babies, promising peace ...
(Date:1/19/2017)... India , January 19, 2017 According to a ... Opportunities and Forecast, 2014 - 2022," the global biometric sensor market is expected ... 2016 to 2022. In 2015, Asia-Pacific dominated the global ... and private sectors. Continue Reading ... ...
(Date:1/18/2017)... Jan. 18, 2017 MedNet Solutions ... supports the entire spectrum of clinical research, is ... record-breaking year for the organization in terms of ... MedNet,s eClinical products and services. The company,s exceptional ... success of iMedNet ™ ...
Breaking Biology News(10 mins):